Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hologic Inc (HOLX)

Hologic Inc (HOLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,897,414
  • Shares Outstanding, K 223,245
  • Annual Sales, $ 4,101 M
  • Annual Income, $ 565,700 K
  • EBIT $ 776 M
  • EBITDA $ 1,076 M
  • 60-Month Beta 0.73
  • Price/Sales 4.11
  • Price/Cash Flow 13.23
  • Price/Book 3.21

Options Overview Details

View History
  • Implied Volatility 9.59% (-0.42%)
  • Historical Volatility 2.54%
  • IV Percentile 16%
  • IV Rank 8.54%
  • IV High 70.57% on 09/17/25
  • IV Low 3.90% on 02/18/26
  • Expected Move (DTE 21) 1.41 (1.86%)
  • Put/Call Vol Ratio 2.11
  • Today's Volume 59
  • Volume Avg (30-Day) 2,934
  • Put/Call OI Ratio 4.14
  • Today's Open Interest 32,190
  • Open Int (30-Day) 33,516
  • Expected Range 74.26 to 77.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.09
  • Number of Estimates 6
  • High Estimate 1.14
  • Low Estimate 1.04
  • Prior Year 1.03
  • Growth Rate Est. (year over year) +5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.00 +0.89%
on 03/16/26
75.75 -0.11%
on 03/26/26
+0.31 (+0.41%)
since 02/27/26
3-Month
74.46 +1.63%
on 12/30/25
75.75 -0.11%
on 03/26/26
+1.17 (+1.57%)
since 12/26/25
52-Week
51.90 +45.80%
on 05/06/25
75.75 -0.11%
on 03/26/26
+13.35 (+21.42%)
since 03/27/25

Most Recent Stories

More News
3 Reasons to Sell HOLX and 1 Stock to Buy Instead

3 Reasons to Sell HOLX and 1 Stock to Buy Instead

HOLX : 75.67 (-0.03%)
Is Hologic Stock Outperforming the Dow?

Although Hologic has exceeded the Dow over the past year, analysts remain cautious about the stock’s prospects.

HOLX : 75.67 (-0.03%)
COO : 69.77 (-2.47%)
$DOWI : 45,166.64 (-1.73%)
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates

Fifth edition of Hologic Global Women’s Health Index reveals over half of women worldwide weren’t tested for key conditions in the past year Hologic and Gallup convene...

HOLX : 75.67 (-0.03%)
1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges

1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges

HOLX : 75.67 (-0.03%)
RELL : 11.04 (-3.16%)
OSIS : 272.33 (-0.86%)
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

MGM : 36.32 (-3.33%)
HOLX : 75.67 (-0.03%)
OMCL : 32.75 (-6.96%)
Is Wall Street Bullish or Bearish on Hologic Stock?

Though Hologic has outperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

HOLX : 75.67 (-0.03%)
XLV : 143.26 (-1.70%)
$SPX : 6,368.85 (-1.67%)
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Expanded FDA approval across multiple cervical cancer screening modalities supports clinical flexibility and provider choice

HOLX : 75.67 (-0.03%)
Hologic: Fiscal Q1 Earnings Snapshot

Hologic: Fiscal Q1 Earnings Snapshot

HOLX : 75.67 (-0.03%)
Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates

Hologic (NASDAQ:HOLX) Misses Q4 CY2025 Revenue Estimates

HOLX : 75.67 (-0.03%)
Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases (9.2%), Non-GAAP Diluted EPS of $1.04 Up 1.0% –

HOLX : 75.67 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

See More

Key Turning Points

3rd Resistance Point 75.87
2nd Resistance Point 75.79
1st Resistance Point 75.73
Last Price 75.67
1st Support Level 75.59
2nd Support Level 75.51
3rd Support Level 75.45

See More

52-Week High 75.75
Last Price 75.67
Fibonacci 61.8% 66.64
Fibonacci 50% 63.83
Fibonacci 38.2% 61.01
52-Week Low 51.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.